Noll Ines, Schweickert Birgitta, Tenhagen Bernd-Alois, Käsbohrer Annemarie
Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Seestraße 10, 13353, Berlin, Deutschland.
Fachgruppe Epidemiologie, Zoonosen und Antibiotikaresistenz, Bundesinstitut für Risikobewertung, Berlin, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):522-532. doi: 10.1007/s00103-018-2724-0.
The German Antimicrobial Resistance Strategy (DART) assigns a key role in combatting and reducing the further development and spread of antimicrobial resistance to the setup and development of instruments for the monitoring and surveillance of antimicrobial resistance and antibiotic consumption. The strategy follows the One Health approach, which targets human and veterinary medicine alike. An ongoing collection of appropriate data on antimicrobial resistance and antibiotic consumption and its distribution in time and space, will provide the basis for the identification of problems, the deduction of interventions, and finally the evaluation of their effectiveness. This article presents an overview of established surveillance systems in human and veterinary medicine with a national scope, including those that enable Germany to meet its own legal commitments as well as those within European and international action plans.
德国抗菌药物耐药性战略(DART)将监测和监督抗菌药物耐药性及抗生素消费的工具的设立与开发,视为对抗和减少抗菌药物耐药性的进一步发展与传播的关键作用。该战略遵循“同一健康”方法,同时针对人类医学和兽医学。持续收集有关抗菌药物耐药性和抗生素消费及其在时间和空间上的分布的适当数据,将为识别问题、推导干预措施以及最终评估其有效性提供基础。本文概述了德国国内在人类医学和兽医学领域已建立的监测系统,包括那些使德国能够履行其自身法律承诺的系统,以及欧洲和国际行动计划中的相关系统。